102 related articles for article (PubMed ID: 35703314)
1. Evaluation protocol for CRISPR/Cas9-mediated CD19 knockout GM24385 cells by flow cytometry and Sanger sequencing.
Inwood SL; Tian L; Parratt K; Maragh S; Wang L
Biotechniques; 2022 Jun; 72(6):279-286. PubMed ID: 35703314
[TBL] [Abstract][Full Text] [Related]
2. Assaying Cell Cycle Progression via Flow Cytometry in CRISPR/Cas9-Treated Cells.
Geisinger JM; Stearns T
Methods Mol Biol; 2021; 2329():195-204. PubMed ID: 34085224
[TBL] [Abstract][Full Text] [Related]
3. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
4. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
6. A simple and highly efficient method for multi-allelic CRISPR-Cas9 editing in primary cell cultures.
Hoellerbauer P; Kufeld M; Arora S; Wu HJ; Feldman HM; Paddison PJ
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1269. PubMed ID: 32721120
[TBL] [Abstract][Full Text] [Related]
7. Ex Vivo Expansion and CRISPR-Cas9 Genome Editing of Primary Human Natural Killer Cells.
Huang RS; Lai MC; Lin S
Curr Protoc; 2021 Sep; 1(9):e246. PubMed ID: 34529358
[TBL] [Abstract][Full Text] [Related]
8. Plasmid-based CRISPR-Cas9 system efficacy for introducing targeted mutations in CD81 gene of MDA-MB-231 cell line.
Arbabi Zaboli K; Rahimi H; Thekkiniath J; Taromchi AH; Kaboli S
Folia Histochem Cytobiol; 2022; 60(1):13-23. PubMed ID: 35157300
[TBL] [Abstract][Full Text] [Related]
9. High efficient multisites genome editing in allotetraploid cotton (Gossypium hirsutum) using CRISPR/Cas9 system.
Wang P; Zhang J; Sun L; Ma Y; Xu J; Liang S; Deng J; Tan J; Zhang Q; Tu L; Daniell H; Jin S; Zhang X
Plant Biotechnol J; 2018 Jan; 16(1):137-150. PubMed ID: 28499063
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
11. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
Ebrahimi V; Hashemi A
Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
[TBL] [Abstract][Full Text] [Related]
12. Profiling Genome-Wide Specificity of CRISPR-Cas9 Using Digenome-Seq.
Kim D; Kim JS
Methods Mol Biol; 2021; 2162():233-242. PubMed ID: 32926386
[TBL] [Abstract][Full Text] [Related]
13. Simple Protocol for Generating and Genotyping Genome-Edited Mice With CRISPR-Cas9 Reagents.
Fernández A; Morín M; Muñoz-Santos D; Josa S; Montero A; Rubio-Fernández M; Cantero M; Fernández J; Del Hierro MJ; Castrillo M; Moreno-Pelayo MÁ; Montoliu L
Curr Protoc Mouse Biol; 2020 Mar; 10(1):e69. PubMed ID: 32159922
[TBL] [Abstract][Full Text] [Related]
14. Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA.
Zhang Y; Ling X; Su X; Zhang S; Wang J; Zhang P; Feng W; Zhu YY; Liu T; Tang X
Angew Chem Int Ed Engl; 2020 Nov; 59(47):20895-20899. PubMed ID: 33448579
[TBL] [Abstract][Full Text] [Related]
15. Genome Editing by CRISPR/Cas9 in Sorghum Through Biolistic Bombardment.
Liu G; Li J; Godwin ID
Methods Mol Biol; 2019; 1931():169-183. PubMed ID: 30652290
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9-mediated genome editing in sea urchins.
Lin CY; Oulhen N; Wessel G; Su YH
Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
[TBL] [Abstract][Full Text] [Related]
17. Precise and efficient scarless genome editing in stem cells using CORRECT.
Kwart D; Paquet D; Teo S; Tessier-Lavigne M
Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
[TBL] [Abstract][Full Text] [Related]
18. Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays.
Deshpande A; Chen BR; Zhao L; Saddoris K; Kerr M; Zhu N; Mali P; Deshpande AJ
J Vis Exp; 2019 Jan; (143):. PubMed ID: 30663717
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
Liu W; Yang C; Liu Y; Jiang G
Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
[TBL] [Abstract][Full Text] [Related]
20. Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells.
Hindriksen S; Bramer AJ; Truong MA; Vromans MJM; Post JB; Verlaan-Klink I; Snippert HJ; Lens SMA; Hadders MA
PLoS One; 2017; 12(6):e0179514. PubMed ID: 28640891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
